A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults
Clinical trial NCT04661839 · COMPLETED
Trial details
- NCT number
- NCT04661839
- Sponsor
- Emergent BioSolutions
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-24
- Primary completion
- 2021-07-27
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.